(Cyclohexylmethyl)urea

CAS : 5472-36-6

Ref. 3D-FAA47236

Informations sur le produit

• Nom: (Cyclohexylmethyl)urea
• Marque: Biosynth
• Description: Cyclohexylmethyl)urea is a protease inhibitor that inhibits the activity of the ns3 protease, which is involved in coagulation. Cyclohexylmethyl)urea binds to the active site of the ns3 protease and prevents it from cleaving proteins. It has been shown to be beneficial for patients who have had angioplasty or other procedures that involve opening a blocked artery. Cyclohexylmethyl)urea is also used for the treatment of restenosis after angioplasty and myocardial infarction. Cyclohexylmethyl)urea is administered intravenously and can be given as an injection or infusion. The drug must be given with a co-administered agent such as hydrochloric acid, which stabilizes cyclohexylmethyl)urea by converting it into its hydrochloride salt. This pharmaceutical preparation is not indicated for use in children under 6 years of age because of its potential to cause irreversible

Propriétés chimiques

• Masse moléculaire: 156.23 g/mol
• Formule: C₈H₁₆N₂O
• Degré de pureté: Min. 95%